APOLLOHOSP
Apollo Hospitals Enterprise Limited
Each stock's 10,000-path forecast, rendered as light.
Apollo Hospitals Enterprise Limited (APOLLOHOSP) Stock Analysis & Case Study
Is APOLLOHOSP a good buy? The data-driven verdict.
Apollo Hospitals Enterprise Limited (APOLLOHOSP) trades at ₹8,945,on the numbers it worth a closer look, a Downstox Snapshot Score of 59/100.
On the numbers, Apollo Hospitals Enterprise Limited (APOLLOHOSP) worth a closer look, a Downstox Snapshot Score of 59/100, weighing expensive at 68.7× earnings, ROE of 21.2%, a 71% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
APOLLOHOSP fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How APOLLOHOSP ranks against the 2,373 companies in our screener
- APOLLOHOSP's market cap of 1.29L Cr ranks in the top 3% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APOLLOHOSP's book value of ₹659 ranks in the 93rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APOLLOHOSP's promoter holding of 28.0% ranks in the 7th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APOLLOHOSP's 3-year profit (PAT) growth of 32.0% ranks in the 71st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APOLLOHOSP's 3-year revenue growth of 15.0% ranks in the 63rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APOLLOHOSP's debt-to-equity ratio of 0.90x is lower than 17% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is APOLLOHOSP overvalued? APOLLOHOSP P/E vs peers
APOLLOHOSP trades at 68.7× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
APOLLOHOSP share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of APOLLOHOSP history (19%/yr drift, 20%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| APOLLOHOSP 2027 | ₹7,731 | ₹10,050 | ₹13,065 | +12% |
| APOLLOHOSP 2028 | ₹7,865 | ₹11,292 | ₹16,213 | +26% |
| APOLLOHOSP 2029 | ₹8,093 | ₹12,688 | ₹19,891 | +42% |
| APOLLOHOSP 2030 | ₹8,480 | ₹14,256 | ₹23,965 | +59% |
| APOLLOHOSP 2031 | ₹8,882 | ₹16,018 | ₹28,886 | +79% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability APOLLOHOSP goes up, or doubles?
The bull case for APOLLOHOSP
- APOLLOHOSP's return on equity of 21.2% ranks in the 86th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A 10,000-path probability model puts a 71% chance the price is higher in a year, with a median target of ₹10,050 (+12%).
- Relatively low volatility (20%/yr), a steadier ride than the typical mid/small-cap.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹19,891.
The bear case & risks
- APOLLOHOSP's P/E of 68.7x is lower than 17% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A steep 13.6× price-to-book means most of the value is intangible/expectations, not assets on the books.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹8,093.
APOLLOHOSP volatility & expected range, how bumpy is the ride?
Over the last 9.8 years APOLLOHOSP compounded at 19%/year with annualized volatility of 20%. That volatility implies a 1-year 80% range of ₹7,731-₹13,065, the honest backbone behind any single price target.
APOLLOHOSP price forecast, the full 60-month probability fan
APOLLOHOSP price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds APOLLOHOSP hits common targets within the simulated horizon?
Full multi-horizon detail on the APOLLOHOSP price target & forecast page.
APOLLOHOSP Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. APOLLOHOSP scores 6/8, mixed financial health.
APOLLOHOSP MTF margin & leverage across 11 brokers
Margin Trading Facility lets you buy APOLLOHOSP with part of the capital. Lower margin % = higher leverage. Rates compared across 11 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 23.00% | 4.3× |
| Zerodha | 22.60% | 4.4× |
| Groww | 22.56% | 4.4× |
| Dhan | 22.00% | 4.5× |
| Kotak NeoCHEAPEST | 20.00% | 5.0× |
| Paytm MoneyCHEAPEST | 20.00% | 5.0× |
| Pocketful | 26.50% | 3.8× |
| Fyers | 27.03% | 3.7× |
| Anand Rathi | 26.50% | 3.8× |
| Bajaj Broking | 23.00% | 4.3× |
| Share India | 26.50% | 3.8× |
Compare every broker on the APOLLOHOSP MTF page.
About Apollo Hospitals Enterprise Limited: sector, index & market-cap context
Apollo Hospitals Enterprise Limited (APOLLOHOSP) is a large-cap NSE-listed company in the Healthcare sector, and a constituent of the Nifty 50 index, with a market capitalisation of ₹1.29L Cr. See more stocks on our screener.
How the APOLLOHOSP Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Apollo Hospitals Enterprise Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
APOLLOHOSP analysis, FAQs
Is Apollo Hospitals Enterprise Limited (APOLLOHOSP) a good buy?
On the numbers, Apollo Hospitals Enterprise Limited (APOLLOHOSP) worth a closer look, a Downstox Snapshot Score of 59/100, weighing expensive at 68.7× earnings, ROE of 21.2%, a 71% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is APOLLOHOSP overvalued or undervalued?
APOLLOHOSP trades at 68.7× earnings, expensive versus the ~22× long-run Nifty average.
What is the APOLLOHOSP share price target for 2031?
APOLLOHOSP's probability-weighted 2031 median target is ₹16,018, with an 80% range of ₹8,882-₹28,886 (10,000-path Monte-Carlo).
What is the probability APOLLOHOSP doubles in 5 years?
The modelled probability of APOLLOHOSP reaching ₹17,890 (2×) within 5 years is 41%.
What is the bull case for APOLLOHOSP?
APOLLOHOSP's return on equity of 21.2% ranks in the 86th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A 10,000-path probability model puts a 71% chance the price is higher in a year, with a median target of ₹10,050 (+12%). Relatively low volatility (20%/yr), a steadier ride than the typical mid/small-cap.
What are the risks in APOLLOHOSP?
APOLLOHOSP's P/E of 68.7x is lower than 17% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A steep 13.6× price-to-book means most of the value is intangible/expectations, not assets on the books.